ArticleWorld journal of urology2026
Role of periaqueductal gray matter in bladder overactivity induced by vesical adaptation response to diuresis in rats.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to elucidate the pathophysiology of overactive bladder (OAB) associated with vesical adaptation response to diuresis (VARD), the homeostatic system adjusting bladder volume in response to diuresis, by identifying regulatory mechanisms for VARD in the brain.
methodsMale 14-week-old Sprague-Dawley rats underwent cystometry with saline infused into the bladder at rates of 0 mL/h (Sham group), 1 mL/h (Low-rate group), or 10 mL/h (High-rate group). Neural activity in the prefrontal cortex (PFC) and periaqueductal gray (PAG) was assessed in each group using c-Fos staining. Effects of ibotenic acid (IBO) destruction of PFC or PAG lesions on VARD were compared using metabolic cage studies and cystometry, assuming that rates of bladder infusion and vesical filling were equal. Control groups received phosphate-buffered saline injections into the PFC or PAG (PBS-PFC and PBS-PAG groups, respectively), while IBO groups received IBO injections into the PFC or PAG (IBO-PFC and IBO-PAG groups, respectively). VARD was defined as a positive correlation (γ > 0.4) between urine output rate and voided volume (VV).
resultsIn both the PFC and PAG, numbers of c-Fos-positive cells were significantly higher in the High-rate group than in the Low-rate group (p < 0.01 each). The IBO-PFC group exhibited decreased VV (p = 0.04) compared to the PBS-PFC group, although VARD was maintained (γ = 0.62). In contrast, the IBO-PAG group showed decreased VV (p = 0.04) compared to the PBS-PAG group and absence of VARD (γ = 0.17).
conclusionThe PAG is responsible for VARD. Dysfunction of the PAG may contribute to OAB due to the absence of VARD.
Indexed as
Identifiers
42557521What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.